Company
ChinaHubei Enoray Biopharmaceutical Co., Ltd., Huanggang, China – FDA Inspections
Inspection records and compliance data for Hubei Enoray Biopharmaceutical Co., Ltd. in Huanggang. 2 FDA inspections on record, last inspected March 13, 2025.
Company Profile
This profile covers Hubei Enoray Biopharmaceutical Co., Ltd. based in Huanggang, China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected July 27, 2017. Last inspected March 13, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 13, 2025 | Not classified | Human Drugs | 1266744 |
| July 27, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1028052 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Zhejiang Top Medicine Co., Ltd.
Shandong Excel Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Co., Ltd.
Inner Mongolia Glint Pharmaceutical Co., Ltd.
Wuhan Wuyao Pharmaceutical Co., Ltd.
Xinjiang Nuziline Biopharmaceutical Co., Ltd.
Asymchem Laboratories (Tianjin) Co., Ltd.
Henan Topfond Sci-Tech Co., Ltd.
Shangai Acana Pharmtech Co., Ltd
Zhejiang Changhai Pharmaceuticals Co., Ltd.
Company Information
Name
Hubei Enoray Biopharmaceutical Co., Ltd.
FEI Number
3010165284
Address
No. 108 Yanjiang Road, Huangmeixian, Huanggang, China
Country
China
ID: cc6f2be6-a1a6-4abf-832b-620aebc474a3